We are live on ! Find out more
ECM

ETrade Capital Management Portfolio holdings

AUM $5.37B
1-Year Est. Return 10.84%
This Fund
S&P 500
This Quarter Est. Return
+16.75%
1 Year Est. Return
+10.84%
3 Year Est. Return
+26.27%
5 Year Est. Return
+59.02%
10 Year Est. Return
AUM
$4.79B
AUM Growth
+$872M
Cap. Flow
+$254M
Cap. Flow %
5.3%
Top 10 Hldgs %
41.72%
Holding
937
New
183
Increased
268
Reduced
394
Closed
90

Sector Composition

Rank Sector Weight
1 Miscellaneous 76.91%
2 Technology 5.01%
3 Healthcare 3.91%
4 Financials 3.09%
5 Consumer Discretionary 2.4%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
EGIO
751
DELISTED
Edgio, Inc. Common Stock
EGIO
$219K ﹤0.01%
+745
New +$165K
APH icon
752
Amphenol
APH
$191B
$218K ﹤0.01%
+18,224
New +$203K
CME icon
753
CME Group
CME
$98.9B
$218K ﹤0.01%
1,340
-343
-20% -$61.5K
LRN icon
754
Stride
LRN
$3.47B
$217K ﹤0.01%
+7,982
New +$192K
EVR icon
755
Evercore
EVR
$10.4B
$216K ﹤0.01%
+3,662
New +$199K
REGN icon
756
Regeneron Pharmaceuticals
REGN
$79.7B
$216K ﹤0.01%
346
-343
-50% -$195K
CDP icon
757
COPT Defense Properties
CDP
$3.92B
$215K ﹤0.01%
+8,501
New +$212K
SRPT icon
758
Sarepta Therapeutics
SRPT
$2.19B
$215K ﹤0.01%
1,344
-732
-35% -$99.6K
CWEN.A
759
DELISTED
Clearway Energy Class A
CWEN.A
$214K ﹤0.01%
+10,211
New +$199K
OSK icon
760
Oshkosh
OSK
$8.84B
$214K ﹤0.01%
+2,981
New +$203K
SWKS icon
761
Skyworks Solutions
SWKS
$13.5B
$213K ﹤0.01%
+1,667
New +$185K
NBIX icon
762
Neurocrine Biosciences
NBIX
$15.2B
$212K ﹤0.01%
+1,737
New +$192K
STZ icon
763
Constellation Brands
STZ
$21.1B
$212K ﹤0.01%
1,213
-725
-37% -$121K
FISV
764
Fiserv Inc
FISV
$26.6B
$210K ﹤0.01%
2,154
-4,592
-68% -$462K
RRX icon
765
Regal Rexnord
RRX
$10.2B
$210K ﹤0.01%
+2,401
New +$180K
JKHY icon
766
Jack Henry & Associates
JKHY
$10.8B
$209K ﹤0.01%
+1,136
New +$198K
RDS.A
767
DELISTED
Royal Dutch Shell PLC ADS Class A
RDS.A
$209K ﹤0.01%
+6,382
New +$219K
AVTR icon
768
Avantor
AVTR
$10.4B
$208K ﹤0.01%
+12,244
New +$199K
CADE
769
DELISTED
Cadence Bank
CADE
$208K ﹤0.01%
+9,156
New +$194K
NVRO
770
DELISTED
NEVRO CORP.
NVRO
$208K ﹤0.01%
+1,738
New +$206K
AME icon
771
Ametek
AME
$53.8B
$207K ﹤0.01%
2,319
-7,506
-76% -$630K
CVY icon
772
Invesco Zacks Multi-Asset Income ETF
CVY
$124M
$207K ﹤0.01%
12,617
-2,202
-15% -$34.6K
ST icon
773
Sensata Technologies
ST
$6.06B
$207K ﹤0.01%
+5,568
New +$197K
PDM
774
Piedmont Realty Trust
PDM
$1.19B
$206K ﹤0.01%
12,427
-365
-3% -$6.09K
AZPN
775
DELISTED
ASPEN TECHNOLOGY INC
AZPN
$206K ﹤0.01%
+1,984
New +$206K

Similar funds

ETrade Capital Management's Q2 2020 Portfolio in Review

As of Q2 2020, ETrade Capital Management held 937 positions worth $4.79B, up 22% from $3.92B the previous quarter. Its ten largest holdings account for 42% of the portfolio.

ETrade Capital Management deployed $254M of net new capital in Q2 2020, opening 183 new positions and adding to 268 existing holdings. Its largest new stake was iShares iBoxx $ Investment Grade Corporate Bond ETF: 855,549 shares worth $115M.

By sector, the portfolio is most concentrated in Miscellaneous at 77% of assets, up from 77% a quarter earlier, followed by Technology and Healthcare.

On the sell side, the largest reduction was iShares MSCI USA Quality Factor ETF, an estimated $42.9M trimmed.

  • ETrade Capital Management's largest Q2 2020 buy was iShares iBoxx $ Investment Grade Corporate Bond ETF: 855,549 shares worth $115M.
  • ETrade Capital Management added most to iShares MSCI EAFE Growth ETF in Q2 2020, an estimated $71.1M increase.
  • ETrade Capital Management's biggest Q2 2020 reduction was iShares MSCI USA Quality Factor ETF, cutting an estimated $42.9M.
  • ETrade Capital Management fully exited iShares MSCI USA Size Factor ETF in Q2 2020, selling an estimated $12.4M.
  • ETrade Capital Management's ten largest holdings make up 42% of its $4.79B portfolio in Q2 2020.
  • ETrade Capital Management opened 183 new positions and closed 90 in Q2 2020.
  • ETrade Capital Management's portfolio value rose 22% quarter-over-quarter to $4.79B.

Based on ETrade Capital Management's 13F filing for Q2 2020, filed 13 Aug 2020.